August 2018 - Page 16 of 30

ThursdayAug 16, 2018 11:27 am

Independent Researchers at SeeThruEquity Take Note of Advances at Payment Solutions Company Net Element, Inc. (NASDAQ: NETE)

Rise in transaction volume, product enhancements and asset acquisition show Net Element’s ongoing growth strategy SeeThruEquity labels Net Element an ‘intriguing’ high-risk, high-reward growth company with stable share price target Since 2014, Net Element’s revenues from payment processing services have nearly tripled A series of optimistic developments for payment tech processor Net Element, Inc. (NASDAQ: NETE) has led independent equity research firm SeeThruEquity to issue an update of its coverage on the company (http://ibn.fm/7NBjg). The research firm is taking note of Net Element’s forecast for an increase in gross profits based on its acquisition of services assets from partner Universal Payment…

ThursdayAug 16, 2018 9:57 am

QualityStocksNewsBreaks – Zenergy Brands, Inc. (ZNGY) Reports Q2 Financial Results

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) this morning announced that it has filed its Form 10-Q with the SEC, reporting financials from the second quarter of 2018. The company reported total revenue of $464,404 during the second quarter of 2018, demonstrating an increase of 54% when compared to the total revenue of $301,809 from the previous quarter. Zenergy attributes the revenue growth primarily to the company’s retail electricity services, and energy conservation and efficiency contracts. The company also reported an increase in growth profit of 17% from the previous quarter, totaling $109,315 for Q2. Zenergy’s Zero Cost…

ThursdayAug 16, 2018 9:26 am

QualityStocksNewsBreaks – FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Unveils New FANbassador Program

Fan-focused entertainment company FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) this morning unveiled its new FANbassador Program. The company is giving users and fans of its FANDOM SPORTS app the chance to become contributing writers on the app for a week. Interested users can submit their best sports fights to nick@fandomsports.net. The top three fights with the best headlines and pictures will win a chance to become a paid FANbassador writer for a week. In the future, the company intends to give official FANbassadors a chance to pick a fight and talk trash on the FANDOM…

WednesdayAug 15, 2018 2:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Continues to Demonstrate Versatility

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is the developer of a disruptive drug delivery platform, DehydraTECH™, that the company out-licenses to entities aiming to deliver healthier ingestion methods of cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. An article discussing the company’s technology reads: “Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has applied for one more to the USPTO. This is because, in lab studies, the proprietary technology has shown evidence of transporting active pharmaceutical ingredients (APIs) across…

WednesdayAug 15, 2018 2:22 pm

QualityStocksNewsBreaks –The Flowr Corp. Secures Sales License from Health Canada

The Flowr Corp., a cultivator of premium cannabis in Canada, recently announced that it has received its sales license from Health Canada enabling the company to sell to the Canadian medical and adult-use recreational markets. Initially, Flowr will offer two brands: FlowrRx and Flowr. FlowrRx is a premium quality medicinal cannabis that empowers patients to live improved, fuller lives. The company’s premium recreational adult-use brand, Flowr, will serve the recreational market when it opens in October. “We’re pleased to have successfully completed the rigorous Health Canada sales licensing process and are excited to begin offering consumers and patients the high-quality…

WednesdayAug 15, 2018 12:41 pm

CytoDyn Inc. (CYDY) Sees Promising HIV Treatment Trial Results, Gets Go-Ahead to Raise Dosage

Response rate to PRO 140 rose from 40 percent at 350mg dose to 70 percent at 525mg Institutional Review Board (IRB) allows trials of viral-entry inhibitor to continue at 700mg dose PRO 140 is an FDA fast-track candidate Following clinical trial results showing that its new anti-HIV treatment is more effective at higher dosages, biotechnology company CytoDyn Inc. (OTCQB: CYDY) is set to give trial participants an increased weekly dose of PRO 140 (http://ibn.fm/oyLRe). The latest round of trial results showed that the response rate among trial participants treated with the viral-entry inhibitor rose from 40 percent at a 350mg weekly…

WednesdayAug 15, 2018 12:17 pm

MIDS Cardiac by Zenosense, Inc. (ZENO): A Heart Attack Diagnostic Revolution?

The handheld testing device technology under development by Zenosense aims to deliver rapid results and state-of-the-art, laboratory-accurate results for the quick diagnosis of heart attacks Medical professionals believe that diagnosis within 30 minutes of a heart attack is the golden standard for ensuring adequate treatment Cardiac diagnostic testing market estimated between $2 billion and $6 billion in the U.S. alone MIDS Cardiac™, a handheld diagnostic device for cardiac emergency triage being developed by Zenosense, Inc. (OTCQB: ZENO), could prove to be revolutionary in the diagnostic process. Incorporating the patented MIDS technology, which is predicated on the nano-magnetic detection of assay…

WednesdayAug 15, 2018 12:13 pm

QualityStocksNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Ink Definitive JV Agreement to Develop Cannabis Beverages Inc.

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), together with WeedMD (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the companies have signed a final definitive Joint Venture (“JV”) agreement to develop and operate Cannabis Beverages Inc. (“CanBev”). The strategic partnership positions CanBev as an early mover in the cannabis-infused beverage market, with each company retaining 50% each of the Class A shares in the new company. CanBev’s Board of Directors will be comprised of five individuals, two nominated by each company and one independent director. The partners have agreed to fund capital requirements of CanBev equally, beginning with initial…

WednesdayAug 15, 2018 11:55 am

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Approaches Full Capacity Oil Extraction in Test of Proprietary Closed-Loop Technology

New equipment, Cavitation Technologies agreement boosting efficiency as Petroteq launches environmentally friendly operations Company awaiting word on its application to uplist to Nasdaq Capital Market Petroteq expects to begin production at 1,000 barrels per day and ramp up to 8,000 barrels within about two years Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), a company actively proving its environmentally friendly, proprietary oil extraction technology, has announced the completion of continuity testing as it builds up to full capacity extraction of 1,000 barrels of oil per day utilizing the technology at its Asphalt Ridge facility in Utah’s desert tar sand-rich…

WednesdayAug 15, 2018 11:25 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Inks Licensing Agreement with Asterion Cannabis; Engages Monster Media to Provide IR Services

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has signed an agreement with Asterion Cannabis Inc. to acquire a worldwide license to use, manufacture, distribute and sell three Health Canada approved natural health products. Per the terms of the licensing agreement, Asterion has granted PreveCeutical a non-exclusive license to use Asterion's intellectual property to make or have made, use, distribute, sell, offer to sell and promote the products in exchange for a royalty fee payable to Asterion equaling 20% of the gross sales. The licensing agreement’s initial term is five years and…

Site Search

Company Search

Month: August 2018